Black Rock Inc. Akebia Therapeutics, Inc. Transaction History

Black Rock Inc.

$4.23 Trillion
Q1 2024

A detailed history of Black Rock Inc. transactions in Akebia Therapeutics, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 2,539,225 shares of AKBA stock, worth $2.84 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,539,225

Previous 3,122,824 18.69%

Holding current value

$2.84 Million

Previous $3.87 Million 19.99%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	SELL	$1.27 - $2.24 $741,170 - $1.31 Million	-583,599 Reduced 18.69%	2,539,225 $4.65 Million
Q4 2023 Feb 13, 2024	BUY	$0.8 - $1.28 $535,240 - $856,385	669,051 Added 27.27%	3,122,824 $3.87 Million
Q3 2023 Nov 13, 2023	SELL	$0.87 - $1.84 $246,282 - $520,872	-283,083 Reduced 10.34%	2,453,773 $2.8 Million
Q2 2023 Aug 11, 2023	BUY	$0.51 - $1.43 $16,999 - $47,666	33,333 Added 1.23%	2,736,856 $2.52 Million
Q1 2023 May 12, 2023	SELL	$0.56 - $1.15 $122,652 - $251,875	-219,022 Reduced 7.49%	2,703,523 $1.51 Million

Q4 2022 Feb 13, 2023	SELL	$0.25 - $0.58 $341,102 - $791,358	-1,364,411 Reduced 31.83%	2,922,545 $1.7 Million
Q3 2022 Nov 14, 2022	SELL	$0.32 - $0.46 $16,982 - $24,412	-53,070 Reduced 1.22%	4,286,956 $1.36 Million
Q2 2022 Aug 12, 2022	SELL	$0.32 - $0.67 $3.08 Million - $6.45 Million	-9,621,514 Reduced 68.91%	4,340,026 $1.53 Million
Q1 2022 May 12, 2022	SELL	$0.72 - $2.93 $117,126 - $476,637	-162,675 Reduced 1.15%	13,961,540 $10 Million
Q4 2021 Feb 10, 2022	BUY	$2.26 - $3.34 $162,105 - $239,571	71,728 Added 0.51%	14,124,215 $31.9 Million
Q3 2021 Nov 09, 2021	BUY	$2.35 - $3.88 $2.06 Million - $3.41 Million	877,806 Added 6.66%	14,052,487 $40.5 Million
Q2 2021 Aug 11, 2021	BUY	$2.83 - $4.2 $37.3 Million - $55.3 Million	13,174,681 New	13,174,681 $49.9 Million

Others Institutions Holding AKBA

# of Institutions

127

Shares Held

56.7M

Call Options Held

937K

Put Options Held

743K

View Full List

About Akebia Therapeutics, Inc.

Ticker AKBA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 183,848,992
Market Cap $206M
Description
Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with kidney diseases. The company's lead product investigational product candidate is vadadustat, an oral therapy, which is in Phase III development for the treatment of anemia due to chronic kidney disease (CKD) ...

More about AKBA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.

Account